BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 16752713)

  • 41. First clinical experience with the Incor left ventricular assist device.
    Schmid C; Tjan TD; Etz C; Schmidt C; Wenzelburger F; Wilhelm M; Rothenburger M; Drees G; Scheld HH
    J Heart Lung Transplant; 2005 Sep; 24(9):1188-94. PubMed ID: 16143232
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy.
    Esmore D; Kaye D; Spratt P; Larbalestier R; Ruygrok P; Tsui S; Meyers D; Fiane AE; Woodard J
    J Heart Lung Transplant; 2008 Jun; 27(6):579-88. PubMed ID: 18503955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preoperative risk factors for mortality after biventricular assist device implantation.
    Zahr F; Ootaki Y; Starling RC; Smedira NG; Yamani M; Thuita L; Fukamachi K
    J Card Fail; 2008 Dec; 14(10):844-9. PubMed ID: 19041048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device.
    Bruggink AH; van Oosterhout MF; De Jonge N; Gmelig-Meyling FH; De Weger RA
    Transpl Immunol; 2008 Apr; 19(1):64-8. PubMed ID: 18346639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Arterial-wave reflections are increased in heart failure patients with a left-ventricular assist device.
    Schofield RS; Pierce GL; Nichols WW; Klodell CT; Aranda JM; Pauly DF; Hill JA; Braith RW
    Am J Hypertens; 2007 Jun; 20(6):622-8. PubMed ID: 17531918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac recovery during mechanical assist device support.
    Maybaum S; Kamalakannan G; Murthy S
    Semin Thorac Cardiovasc Surg; 2008; 20(3):234-46. PubMed ID: 19038734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of patients with end-stage heart disease treated with an implantable left ventricular assist device in a nontransplanting center.
    Peterzén B; Granfeldt H; Lönn U; Carnstam B; Nylander E; Dahlström U; Rutberg H; Casimir-Ahn H
    J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):438-43. PubMed ID: 10972612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Papworth experience with the Levitronix CentriMag ventricular assist device.
    Shuhaiber JH; Jenkins D; Berman M; Parameshwar J; Dhital K; Tsui S; Large SR
    J Heart Lung Transplant; 2008 Feb; 27(2):158-64. PubMed ID: 18267221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation.
    Piacentino V; Troupes CD; Ganapathi AM; Blue LJ; Mackensen GB; Swaminathan M; Felker GM; Stafford-Smith M; Lodge AJ; Rogers JG; Milano CA
    Ann Thorac Surg; 2011 Oct; 92(4):1414-8; discussion 1418-9. PubMed ID: 21958790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation.
    Dang NC; Topkara VK; Kim BT; Mercando ML; Kay J; Naka Y
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1302-9. PubMed ID: 16256782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?
    Levy WC; Mozaffarian D; Linker DT; Farrar DJ; Miller LW;
    J Heart Lung Transplant; 2009 Mar; 28(3):231-6. PubMed ID: 19285613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
    Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal function and outcome after continuous flow left ventricular assist device implantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Grimm M; Wolner E; Wieselthaler GM
    Ann Thorac Surg; 2009 Apr; 87(4):1072-8. PubMed ID: 19324130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bridge to heart transplantation with left ventricular assist device versus inotropic agents in status 1 patients.
    Sasaki H; Mitchell JD; Jessen ME; Lavingia B; Kaiser PA; Comeaux A; Dimaio JM; Meyer DM
    J Card Surg; 2009; 24(6):756-62. PubMed ID: 19754680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utility of concomitant tricuspid valve procedures for patients undergoing implantation of a continuous-flow left ventricular device.
    Piacentino V; Ganapathi AM; Stafford-Smith M; Hsieh MK; Patel CB; Simeone AA; Rogers JG; Milano CA
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1217-21. PubMed ID: 22938779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac extracorporeal life support: state of the art in 2007.
    Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
    Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.
    Rogers JG; Aaronson KD; Boyle AJ; Russell SD; Milano CA; Pagani FD; Edwards BS; Park S; John R; Conte JV; Farrar DJ; Slaughter MS;
    J Am Coll Cardiol; 2010 Apr; 55(17):1826-34. PubMed ID: 20413033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices.
    Garatti A; Bruschi G; Colombo T; Russo C; Lanfranconi M; Milazzo F; Frigerio M; Vitali E
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):275-80; discussion 280. PubMed ID: 18375138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure.
    Welp H; Rukosujew A; Tjan TD; Hoffmeier A; Kösek V; Scheld HH; Drees G
    Thorac Cardiovasc Surg; 2010 Feb; 58 Suppl 2():S185-8. PubMed ID: 20101537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device.
    Slaughter MS; Tsui SS; El-Banayosy A; Sun BC; Kormos RL; Mueller DK; Massey HT; Icenogle TB; Farrar DJ; Hill JD;
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1573-80. PubMed ID: 17532959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.